Atlas Capital Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,700
| Closed | -$75.9K | – | 909 |
|
|
2022
Q3 | $75.9K | Buy |
+2,700
| New | +$75.9K | 0.01% | 483 |
|
|
2022
Q2 | – | Sell |
-2,700
| Closed | -$92K | – | 981 |
|
|
2022
Q1 | $92K | Hold |
2,700
| – | – | 0.01% | 480 |
|
|
2021
Q4 | $104K | Hold |
2,700
| – | – | 0.02% | 448 |
|
|
2021
Q3 | $146K | Hold |
2,700
| – | – | 0.02% | 394 |
|
|
2021
Q2 | $90.3K | Sell |
2,700
-300
| -10% | -$10K | 0.02% | 460 |
|
|
2021
Q1 | $61.8K | Hold |
3,000
| – | – | 0.01% | 476 |
|
|
2020
Q4 | $52.6K | Buy |
+3,000
| New | +$52.6K | 0.01% | 462 |
|